Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
109,5 USD | +1,89 % | -0,44 % | -11,01 % |
Resumen de negocios
Número de empleados: 2 800
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 3 659 | 100,0 % | 3 834 | 100,0 % | +4,78 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
91,0
%
| 3 370 | 92,1 % | 3 490 | 91,0 % | +3,55 % |
Europe
7,0
%
| 240 | 6,5 % | 269 | 7,0 % | +12,35 % |
All Other
2,0
%
| 49 | 1,3 % | 75 | 2,0 % | +51,92 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Bruce Cozadd
CEO | Chief Executive Officer | 60 | 01/03/03 |
Renée Galá
PSD | President | 52 | 16/03/20 |
Robert Iannone
CTO | Chief Tech/Sci/R&D Officer | 57 | 29/05/19 |
Seamus Mulligan
BRD | Director/Board Member | 63 | 18/01/12 |
Andrea N. Flynn
IRC | Investor Relations Contact | - | - |
Shawn Mindus
PRN | Corporate Officer/Principal | - | - |
John Miller
PRN | Corporate Officer/Principal | - | - |
Heidi Manna
HRO | Human Resources Officer | 53 | 01/11/18 |
Neena Patil
LAW | General Counsel | 49 | 01/07/19 |
Aislinn Doody
SEC | Corporate Secretary | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Bruce Cozadd
CEO | Chief Executive Officer | 60 | 01/03/03 |
Norbert Riedel
BRD | Director/Board Member | 66 | 13/05/13 |
Patrick Enright
BRD | Director/Board Member | 62 | 01/01/09 |
Peter Gray
BRD | Director/Board Member | 69 | 08/05/13 |
Ken O'Keefe
BRD | Director/Board Member | 57 | 01/01/04 |
Rick Winningham
BRD | Director/Board Member | 64 | 01/01/10 |
Seamus Mulligan
BRD | Director/Board Member | 63 | 18/01/12 |
Heather McSharry
BRD | Director/Board Member | 62 | 02/05/13 |
Catherine Sohn
BRD | Director/Board Member | 71 | 27/07/12 |
Anne O’Riordan
BRD | Director/Board Member | 56 | 14/02/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 62 345 283 | 60 588 007 ( 97,18 %) | 0 | 97,18 % |
Información de la empresa
Jazz Pharmaceuticals Plc
Waterloo Exchange Waterloo Road
4, Dublin
+353 1 634 7800
http://www.jazzpharmaceuticals.comEmpresas del grupo
Nombre | Categoría y sector |
---|---|
Jazz Pharmaceuticals Ireland Ltd.
Jazz Pharmaceuticals Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Ireland Ltd. is an Irish biopharmaceutical company that focuses on the identification, development, and commercialization of pharmaceutical products. The private company is based in Dublin, Ireland. The company was founded by Bruce C. Cozadd, who has been the CEO since incorporation. |
Pharmaceuticals: Major
|
Jazz Financing I DAC
|
Finance/Rental/Leasing
|
Jazz Securities DAC
|
Finance/Rental/Leasing
|
Jazz Investments II Ltd.
|
Finance/Rental/Leasing
|
Jazz Financing Lux SARL
Jazz Financing Lux SARL Finance/Rental/LeasingFinance Part of Jazz Pharmaceuticals Plc, Jazz Financing Lux SARL provides financing services. The private company is based in Luxembourg, Luxembourg. Founded in 2013. |
Finance/Rental/Leasing
|
Jazz Investments Europe Ltd.
| |
Jazz Pharmaceuticals Ireland Holdings Ltd.
| |
Jazz Financing Holdings Ltd.
|
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-11,01 % | 6824,31 M | |
+25,83 % | 661 mil M | |
+27,00 % | 566 mil M | |
-6,76 % | 352 mil M | |
+20,34 % | 332 mil M | |
+3,00 % | 283 mil M | |
+13,09 % | 231 mil M | |
+5,46 % | 200 mil M | |
-9,61 % | 195 mil M | |
-6,26 % | 145 mil M |
- Bolsa de valores
- Acciones
- Acción JAZZ
- Empresa Jazz Pharmaceuticals plc